Evidence map›Paper›PMID 41680415›Full record

ArticleScientific reports2026

DeepRetro discovers retrosynthetic pathways through iterative large language model reasoning.

Shreyas Vinaya Sathyanarayana, Sharanabasava D Hiremath, Shah Rahil Kirankumar, Rishikesh Panda, Rahul Jana, Riya Singh, Rida Irfan, Ashwin Murali, Bharath Ramsundar

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shreyas Vinaya Sathyanarayana *Deep Forest Sciences, Palo Alto, CA, USA. shreyas@deepforestsci.com.
Sharanabasava D Hiremath *Deep Forest Sciences, Palo Alto, CA, USA.
Shah Rahil Kirankumar *Deep Forest Sciences, Palo Alto, CA, USA.
Rishikesh Panda *Deep Forest Sciences, Palo Alto, CA, USA.
Rahul JanaDeep Forest Sciences, Palo Alto, CA, USA.
Riya SinghDeep Forest Sciences, Palo Alto, CA, USA.
Rida IrfanDeep Forest Sciences, Palo Alto, CA, USA.
Ashwin MuraliDeep Forest Sciences, Palo Alto, CA, USA.
Bharath RamsundarDeep Forest Sciences, Palo Alto, CA, USA. bharath@deepforestsci.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthesizing complex natural products is a grand challenge in organic chemistry. We present DeepRetro, a significant advancement in computational retrosynthesis that discovers viable synthetic routes for molecules previously considered too complex for automated methods. DeepRetro is a novel, open-source framework that tightly integrates large language models (LLMs), traditional retrosynthetic engines, and expert human feedback into an iterative design loop. Unlike prior approaches that rely on either template-based methods or unconstrained LLMs, our hybrid system combines the precision of templates with the generative flexibility of LLMs, governed by rigorous chemical validity checks and recursive refinement. This system dynamically explores and revises synthetic pathways, guided by algorithmic checks and expert input through an interactive interface. While DeepRetro shows strong performance on standard benchmarks, its main strength is its ability to propose novel, viable pathways for highly complex natural products. Through case studies, we demonstrate how this approach facilitates new total synthesis routes and enhances human-machine collaboration. DeepRetro serves as a working model for applying LLMs to scientific discovery, and we release it as an open-source tool to accelerate progress in drug discovery and materials design.

Indexed as

AICASPChemistryDeepRetroDrug discoveryLLMsMachine learningRetrosynthesis

Identifiers

PMID41680415
PMCPMC12972040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.